损害记忆的Anti-P抗体会扰乱海马体的谷氨酸受体贩运,突触结构和微质细胞
Nicole Díaz-Valdivia1,2,3, Mariana Labarca1, Claudio Retamal1,4
1Centro de Biología Celular y Biomedicina (CEBICEM), Facultad de Ciencias, Universidad San Sebastián, Av. Del Valle Norte 725, 8580704, Huechuraba, Santiago, Chile.
Molecular medicine (Cambridge, Mass.)
|September 27, 2025
概括
抗核素P蛋白自身抗体 (anti-P) 通过破坏谷氨酸受体功能和神经元结构来损害记忆力. 这些发现为神经精神病性狼和潜在的治疗点提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 系统性红斑狼 (SLE) 是一种
背景情况:
- 抗核素P蛋白自身抗体 (anti-P) 与SLE患者的精神病和认知缺陷有关.
- 与抗P相关的认知功能障碍背后的机制,包括对质质突触的影响,尚未完全理解.
研究的目的:
- 调查抗P对谷氨酸受体表达和神经元贩运的急性影响.
- 在小鼠模型中确定抗P对海马结构和空间记忆的长期影响.
主要方法:
- 通过免疫光和FRAP在培养的海马神经元中评估NMDAR和AMPAR表面表达和循环.
- 在小鼠中诱导抗P,并使用水迷宫测试评估空间记忆.
- 对受体水平,酸酶活性,神经元密度,微质形态和树突结构进行分析.
主要成果:
- 抗P降低了关键谷氨酸受体 (GluN2A,GluA1,SEP-GluN2A,SEP-GluN2B) 的表面表达和受损的循环.
- 接受抗P治疗的小鼠表现出持续的空间记忆缺陷,神经元损失,改变的微质结构和减少的树突脊柱密度.
- 在抗P小鼠中观察到酸酶PTPMEG的水平增加,此前的突触后密度蛋白质损失.
结论:
- 反P抗体会严重破坏谷氨酸受体的功能,导致长期记忆障碍.
- 持续的认知缺陷与结构性大脑变化和升高的PTPMEG水平有关.
- 研究结果阐明了抗P在认知功能障碍中的作用,并建议神经精神病性SLE的潜在治疗途径.
相关概念视频
01:23Role of Neurotransmitters in Memory
2.5K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.5K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:19Role of Hippocampus in Memory
1.4K
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
1.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
898
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
898
01:22Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560